• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

National Institute for Health and Clinical Excellence (NICE) - Articles and news items

daklinza

NICE recommends Daklinza for chronic HCV

Industry news / 16 October 2015 / Victoria White

NICE has recommended Daklinza for the treatment of patients with chronic hepatitis C virus genotypes 1, 3 and 4…

keytruda

Another NICE recommendation for melanoma drug Keytruda

Industry news / 9 October 2015 / Victoria White

This new recommendation for Keytruda is for treating advanced melanoma that has not been previously treated with ipilimumab…

pembrolizumab

NICE says ‘yes’ to pembrolizumab for advanced melanoma

Industry news / 7 October 2015 /

Pembrolizumab was the first drug to be approved through the Medicines and Healthcare Products Regulatory Agency’s Early Access to Medicine Scheme (EAMS)…

idelalisib

NICE recommends idelalisib for chronic lymphocytic leukaemia

Industry news / 24 September 2015 / Victoria White

Idelalisib has been recommended in combination with rituximab for adults with chronic lymphocytic leukaemia (CLL) who have relapsed early…

edoxaban

NICE recommends blood-thinning drug edoxaban

Industry news / 23 September 2015 / Victoria White

NICE has issued its final recommendation for edoxaban to help prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation…

melanoma-pembrolizumab

NICE recommends melanoma drug pembrolizumab

Industry news / 7 September 2015 / Victoria White

NICE has recommended that pembrolizumab is made available on the NHS as a treatment for some patients with advanced melanoma which is either unresectable or metastatic…

roactemra

NICE recommends RoActemra for severe rheumatoid arthritis

Industry news / 4 September 2015 / Victoria White

RoActemra has been recommended by NICE for the treatment of patients with severe rheumatoid arthritis whose disease has not responded to intensive therapy with a combination of cDMARDs…

apremilast

NICE says ‘no’ to apremilast for psoriatic arthritis

Industry news / 3 September 2015 / Victoria White

NICE has published final draft guidance which does not recommend apremilast, saying that there is not enough evidence to demonstrate apremilast slows progression of psoriatic arthritis…

vimizim

NICE draft guidance conditionally recommends Vimizim

Industry news / 2 September 2015 / Victoria White

NICE has provisionally recommended BioMarin’s Vimizim for the treatment of the very rare inherited lysosomal storage disease, mucopolysaccharidosis type IVa…

vedolizumab

NICE recommends vedolizumab for Crohn’s Disease

Industry news / 26 August 2015 / Victoria White

NICE has recommended Vedolizumab, the first gut-selective treatment for Crohn’s Disease, for use on the NHS, recognising the innovation of the treatment…

clot-edoxaban

NICE recommends edoxaban for deep vein thrombosis

Industry news / 26 August 2015 / Victoria White

NICE has recommended once-daily edoxaban for the treatment and prevention of recurrent DVT and pulmonary embolism, saying the drug is cost-effective for the NHS…

antibiotics

NICE tackles overuse of antibiotics

Industry news / 18 August 2015 / Victoria White

NICE, the UK health watchdog, has published guidance to help doctors, nurses and pharmacists promote and monitor the sensible use of antibiotics…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +